Nepal Clinical Trials Registry (NCTR)

PROJECT STATUS
9-members Clinical Trials Registry sub-committee was formed on Dec 10, 2018, including representatives of WHO, MoHP, Department of Drug Administration, NHRC executives, secretariat and staffs and series of the meeting was conducted.

PROJECT DURATION
2019 onward

ESTIMATED BUDGET

COLLABORATION
Ministry of Health and population (MoHP) and World Health Organisation (WHO)

DISTRICT (S)

BACKGROUND

A Nepal clinical trials registry is an official platform and catalog for registering a clinical trial. NCTR will be an electronic system. In the NCTR system, researcher/sponsor will create their individual account and submit the details of their trial as demanded by the system. A registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes.

OBJECTIVE (S)

To ensure a single point of access and the unambiguous identification of trials with a view to enhancing access to information by patients, families, patient groups and others.

EXPECTED OUTPUT (S)

The WHO Registry Network as a Primary Registries available in International Clinical Trials Registry Platform (ICTRP)